评估沙特阿拉伯COVID-19康复患者对疫苗接种的担忧

IF 1.7 4区医学 Q3 HEALTH CARE SCIENCES & SERVICES

Eastern Mediterranean Health Journal Pub Date : 2023-04-27 DOI:10.26729/emhj.23.027

Mohammed Alrowaily, Turky Alkhathlan, Abdulrahman Alaql, Ibrahim Almesned, Hadeel Alrowaily, Nada Alayed, Mostafa Abolfotouh

{"title":"评估沙特阿拉伯COVID-19康复患者对疫苗接种的担忧","authors":"Mohammed Alrowaily, Turky Alkhathlan, Abdulrahman Alaql, Ibrahim Almesned, Hadeel Alrowaily, Nada Alayed, Mostafa Abolfotouh","doi":"10.26729/emhj.23.027","DOIUrl":null,"url":null,"abstract":"Background: Vaccine hesitancy re-emerged as a critical public health issue during the COVID-19 pandemic.Aims: This study assessed the concerns of recovered COVID-19 patients about vaccination and the predictors of vaccine hesitancy.Methods: This was a cross-sectional study of 319 adult patients who recovered from COVID-19 in Saudi Arabia. It was conducted during 1 May to 1 October 2020 at King Abdulaziz Medical City, Riyadh. Each participant was interviewed 6-12 months post-recovery using the vaccination attitude examination scale. Data were collected on COVID-19 illness severity, sociodemographic characteristics, history of chronic disease, and post-COVID-19 vaccination. Level of vaccination concern was assessed based on the percentage mean score (PMS).Results: Most (85.3%) of the patients who recovered from COVID-19 expressed moderate overall concern (PMS = 68.96%) about vaccination. Concern was highest for mistrust in vaccine benefits (PMS = 90.28%), followed by natural immunity preference (PMS = 81.33%) and worries about the vaccine side-effects (PMS = 60.29%). Concern over commercial profiteering was low (PMS = 43.92%). The overall PMS for concern about vaccination was significantly higher among patients aged 45+ years (t = 3.12, P = 0.002) and among those who had experienced severe COVID-19 illness (t = 1.96, P = 0.05).Conclusion: Overall concern about vaccination was high, and specific concerns were prevalent. Patient education on how the vaccine protects against reinfection should be targeted at COVID-19 patients before being discharged from hospital.","PeriodicalId":11411,"journal":{"name":"Eastern Mediterranean Health Journal","volume":"29 4","pages":"276-284"},"PeriodicalIF":1.7000,"publicationDate":"2023-04-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Assessment of concerns about vaccination among recovered COVID-19 patients in Saudi Arabia.\",\"authors\":\"Mohammed Alrowaily, Turky Alkhathlan, Abdulrahman Alaql, Ibrahim Almesned, Hadeel Alrowaily, Nada Alayed, Mostafa Abolfotouh\",\"doi\":\"10.26729/emhj.23.027\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Background: Vaccine hesitancy re-emerged as a critical public health issue during the COVID-19 pandemic.Aims: This study assessed the concerns of recovered COVID-19 patients about vaccination and the predictors of vaccine hesitancy.Methods: This was a cross-sectional study of 319 adult patients who recovered from COVID-19 in Saudi Arabia. It was conducted during 1 May to 1 October 2020 at King Abdulaziz Medical City, Riyadh. Each participant was interviewed 6-12 months post-recovery using the vaccination attitude examination scale. Data were collected on COVID-19 illness severity, sociodemographic characteristics, history of chronic disease, and post-COVID-19 vaccination. Level of vaccination concern was assessed based on the percentage mean score (PMS).Results: Most (85.3%) of the patients who recovered from COVID-19 expressed moderate overall concern (PMS = 68.96%) about vaccination. Concern was highest for mistrust in vaccine benefits (PMS = 90.28%), followed by natural immunity preference (PMS = 81.33%) and worries about the vaccine side-effects (PMS = 60.29%). Concern over commercial profiteering was low (PMS = 43.92%). The overall PMS for concern about vaccination was significantly higher among patients aged 45+ years (t = 3.12, P = 0.002) and among those who had experienced severe COVID-19 illness (t = 1.96, P = 0.05).Conclusion: Overall concern about vaccination was high, and specific concerns were prevalent. Patient education on how the vaccine protects against reinfection should be targeted at COVID-19 patients before being discharged from hospital.\",\"PeriodicalId\":11411,\"journal\":{\"name\":\"Eastern Mediterranean Health Journal\",\"volume\":\"29 4\",\"pages\":\"276-284\"},\"PeriodicalIF\":1.7000,\"publicationDate\":\"2023-04-27\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Eastern Mediterranean Health Journal\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.26729/emhj.23.027\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"HEALTH CARE SCIENCES & SERVICES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Eastern Mediterranean Health Journal","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.26729/emhj.23.027","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"HEALTH CARE SCIENCES & SERVICES","Score":null,"Total":0}

引用次数: 0

摘要

背景:在COVID-19大流行期间，疫苗犹豫再次成为一个关键的公共卫生问题。目的:本研究评估COVID-19康复患者对疫苗接种的担忧及疫苗犹豫的预测因素。方法:这是一项对沙特阿拉伯319名从COVID-19康复的成年患者进行的横断面研究。该试验于2020年5月1日至10月1日在利雅得阿卜杜勒阿齐兹国王医疗城进行。每个参与者在康复后6-12个月使用疫苗接种态度检查量表进行访谈。收集了COVID-19疾病严重程度、社会人口统计学特征、慢性病史和COVID-19后疫苗接种的数据。根据百分比平均评分(PMS)评估疫苗接种关注水平。结果:大多数(85.3%)新冠肺炎康复患者对疫苗接种表示中度总体担忧(PMS = 68.96%)。对疫苗益处不信任的担忧最高(PMS = 90.28%)，其次是自然免疫偏好(PMS = 81.33%)和对疫苗副作用的担忧(PMS = 60.29%)。对商业暴利的担忧较低(PMS = 43.92%)。45岁以上的患者(t = 3.12, P = 0.002)和经历过严重COVID-19疾病的患者(t = 1.96, P = 0.05)对疫苗接种的担忧总体PMS显著高于对照组(t = 3.12, P = 0.002)。结论:预防接种总体关注度高，个别关注度高。应在出院前针对COVID-19患者进行疫苗预防再感染的患者教育。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Assessment of concerns about vaccination among recovered COVID-19 patients in Saudi Arabia.

Background: Vaccine hesitancy re-emerged as a critical public health issue during the COVID-19 pandemic.

Aims: This study assessed the concerns of recovered COVID-19 patients about vaccination and the predictors of vaccine hesitancy.

Methods: This was a cross-sectional study of 319 adult patients who recovered from COVID-19 in Saudi Arabia. It was conducted during 1 May to 1 October 2020 at King Abdulaziz Medical City, Riyadh. Each participant was interviewed 6-12 months post-recovery using the vaccination attitude examination scale. Data were collected on COVID-19 illness severity, sociodemographic characteristics, history of chronic disease, and post-COVID-19 vaccination. Level of vaccination concern was assessed based on the percentage mean score (PMS).

Results: Most (85.3%) of the patients who recovered from COVID-19 expressed moderate overall concern (PMS = 68.96%) about vaccination. Concern was highest for mistrust in vaccine benefits (PMS = 90.28%), followed by natural immunity preference (PMS = 81.33%) and worries about the vaccine side-effects (PMS = 60.29%). Concern over commercial profiteering was low (PMS = 43.92%). The overall PMS for concern about vaccination was significantly higher among patients aged 45+ years (t = 3.12, P = 0.002) and among those who had experienced severe COVID-19 illness (t = 1.96, P = 0.05).

Conclusion: Overall concern about vaccination was high, and specific concerns were prevalent. Patient education on how the vaccine protects against reinfection should be targeted at COVID-19 patients before being discharged from hospital.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Eastern Mediterranean Health Journal HEALTH CARE SCIENCES & SERVICESPUBLIC, ENV-PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH

CiteScore

3.30

自引率

4.80%

发文量

112

期刊介绍： The Eastern Mediterranean Health Journal, established in 1995, is the flagship health periodical of the World Health Organization Regional Office for the Eastern Mediterranean. The mission of the Journal is to contribute to improving health in the Eastern Mediterranean Region by publishing and publicising quality health research and information with emphasis on public health and the strategic health priorities of the Region. It aims to: further public health knowledge, policy, practice and education; support health policy-makers, researchers and practitioners; and enable health professionals to remain informed of developments in public health. The EMHJ: -publishes original peer-reviewed research and reviews in all areas of public health of relevance to the Eastern Mediterranean Region -encourages, in particular, research related to the regional health priorities, namely: health systems strengthening; emergency preparedness and response; communicable diseases; noncommunicable diseases and mental health; reproductive, maternal, child health and nutrition -provides up-to-date information on public health developments with special reference to the Region. The Journal addresses all members of the health profession, health educational institutes, as well as governmental and nongovernmental organizations in the area of public health within and outside the Region.